You have 9 free searches left this month | for more free features.

MicroRNA

Showing 1 - 25 of 768

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MicroRNA-1 and MicroRNA-133a Levels After Acute Exercise in

Recruiting
  • To Determine the Levels of miRNA1 and miRNA133a Before and After Exercise
  • miRNA levels analysis from saliva samples
  • Istanbul, Turkey
    Yeditepe University
Oct 11, 2023

Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome Trial in Hershey (microRNA-146a level, microRNA-192 level,

Recruiting
  • Neonatal Opioid Withdrawal Syndrome
  • Neonatal Abstinence Syndrome
  • microRNA-146a level
  • +2 more
  • Hershey, Pennsylvania
    Penn State Milton S. Hershey Medical Center
Jun 30, 2023

Measurement of Serum microRNA in Acne Vulgaris Patient

Not yet recruiting
  • Acne Vulgaris
  • measure serum MicroRNA in acne vulgaris
  • (no location specified)
May 23, 2023

Rheumatoid Arthritis Trial in Sakarya (exercise, gene expressions of miRNA)

Completed
  • Rheumatoid Arthritis
  • exercise
  • gene expressions of miRNA
  • Sakarya, Turkey
    Sakarya Training and Research Hospital
Jun 13, 2023

Myocardial Infarction, Acute Trial in Cairo (No intervention)

Completed
  • Myocardial Infarction, Acute
  • No intervention
  • Cairo, Egypt
    Biochemistry Department, Faculty of Pharmacy and Biotechnology,
Jan 18, 2023

GCF miRNA-223 , -214 Levels in Smokers and Nonsmokers

Completed
  • Periodontitis, Adult
  • miRNA-223 & -214 detection
  • Fayoum, Egypt
    faculty of dentistry, Fayoum university
Sep 26, 2023

Osteoarthritis, Knee, Epigenetic Disorder, Quality of Life Trial in Istanbul (Exercise Programme, Experiments)

Completed
  • Osteoarthritis, Knee
  • +4 more
  • Exercise Programme
  • Experiments
  • Istanbul, Turkey
    Bakırköy Dr. Sadi Konuk Training and Hospital Research Hospital,
May 16, 2023

Thyroid Cancer Trial in Toulouse, Montpellier (Signature of 10 microRNA for patients with bethesda classification 3, 4 or 5)

Recruiting
  • Thyroid Cancer
  • Signature of microRNA for patients with bethesda classification 3, 4 or 5
  • Toulouse, Haute-Garonne, France
  • +1 more
Jan 13, 2023

Acute Side Effects In Stage III NSCLC With Definitive CRT

Completed
  • Non-small Cell Lung Cancer Stage III
    • Ankara, Turkey
      Ankara University Medicine School Radiation Oncology
    Aug 22, 2023

    microRNA in Erosive Hand Osteoarthritis and Psoriatic Arthritis

    Completed
    • Erosive Osteoarthritis
    • Psoriatic Arthritis
    • miRNA
    • Siena, Italy
      Rheumatology Unit Azienda Ospedaliera Universitaria Senese
    Jan 4, 2023

    Abortion, Habitual Trial (evacuation)

    Not yet recruiting
    • Abortion, Habitual
    • evacuation
    • (no location specified)
    Dec 27, 2022

    MicroRNA Markers in Head and Neck Cancers

    Active, not recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Tissue collection
    • Aurora, Colorado
      University of Colorado Cancer Center
    Feb 1, 2023

    Gut Microbiota, microRNA Trial in Xi'an (stachyose, Maltodextrin)

    Recruiting
    • Gut Microbiota
    • microRNA
    • stachyose
    • Maltodextrin
    • Xi'an, Shaanxi, China
      the First Affiliate Hospital of the Air Force Medical University
    May 24, 2022

    Multiple Sclerosis, Relapsing-Remitting Trial in Paris (50 ml blodd sampling)

    Not yet recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • 50 ml blodd sampling
    • Paris, France
      Hôpital La Pitié - Salpêtrière
    Aug 16, 2022

    Insulin Resistance Trial in Mexico City (Vegetal protein, Animal protein)

    Recruiting
    • Insulin Resistance
    • Vegetal protein
    • Animal protein
    • Mexico City, Mexico
    • +1 more
    Jan 22, 2023

    Periimplant Soft Tissue Phenotype on Marginal Bone Loss

    Completed
    • Alveolar Bone Loss
    • +2 more
    • Nuclear Factor-Kappa B Ligand (RANKL) analysis
    • +4 more
    • Konya, Turkey
      Necmettin Erbakan University, dentistry Faculty
    Jan 24, 2023

    Plasma MicroRNA for Prediction of Hepatocellular Carcinoma

    Completed
    • Hepatitis C
    • Blood Sampling
    • Banhā, El- Qalyobia, Egypt
      Benha university
    Jul 5, 2022

    MicroRNA Regulation of Chronic Inflammation During Aging

    Not yet recruiting
    • Chronic Inflammation
      • Salt Lake City, Utah
        The University of Utah
      May 24, 2022

      FNA, microRNA, Thyroid Cancer Trial in Jerusalem (Fine needle aspiration)

      Completed
      • FNA
      • +3 more
      • Fine needle aspiration
      • Jerusalem, Israel
        Hadassah Medical Organization
      Mar 15, 2022

      MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer

      Recruiting
      • Gastric Cancer
      • MicroRNAs
      • MicroRNA
      • Bangkok, Not Required For This Country, Thailand
        King Chulalongkorn Memorial Hospital
      Jun 3, 2023

      Endometriosis Trial in University Park (Atorvastatin)

      Recruiting
      • Endometriosis
      • University Park, Pennsylvania
        The Pennsylvania State University
      Apr 8, 2022

      Lung Cancer Trial in Milan (screening)

      Active, not recruiting
      • Lung Cancer
      • screening
      • Milan, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori
      Aug 5, 2022

      Atherosclerosis of Artery Trial in Moscow (blood microRNA, plaque and intima microRNA, histological examination of the plaque)

      Recruiting
      • Atherosclerosis of Artery
      • blood microRNA
      • +3 more
      • Moscow, Russian Federation
        I.M. Sechenov First Moscow State Medical University (Sechenov Un
      Jan 9, 2023

      Acute Graft-versus-Host Disease

      Active, not recruiting
      • Acute Graft-versus-Host Disease
      • Allogeneic Stem Cell Transplant
      • Blood samples
      • Columbus, Ohio
        Ohio State University Medical Center
      Apr 18, 2022

      Epigenetic Silencing of MicroRNA for Predicting Therapeutic

      Active, not recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Not interventional
      • Albuquerque, New Mexico
        University of New Mexico - Cancer Center
      Oct 4, 2022